Skip to main content
Livermore
Livermore
ZHEN

Verrica Pharmaceuticals Inc.

VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660334

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Verrica Pharmaceuticals Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+1 vs. Q3 2022
Shares held
10.8M
+575.0K (+5.6%) vs. Q3 2022
Total value
$29.8M
−$158.3K (−0.5%) vs. Q3 2022
New holders
11
16 more added
Sold out
10
12 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 50 institutions
Q1 2021: 51 institutionsQ2 2021: 53 institutionsQ3 2021: 49 institutionsQ4 2021: 45 institutionsQ1 2022: 51 institutionsQ2 2022: 57 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 60 institutionsQ2 2023: 63 institutionsQ3 2023: 67 institutionsQ4 2023: 64 institutionsQ1 2024: 62 institutionsQ2 2024: 74 institutionsQ3 2024: 79 institutionsQ4 2024: 81 institutionsQ1 2025: 75 institutionsQ2 2025: 59 institutionsQ3 2025: 34 institutionsQ4 2025: 50 institutionsQ1 2026: 39 institutionsQ2 2026: 43 institutions
Value heldQ4 2022: $29.8M
Q1 2021: $150.4MQ2 2021: $112.3MQ3 2021: $114.6MQ4 2021: $82.0MQ1 2022: $72.1MQ2 2022: $21.8MQ3 2022: $29.9MQ4 2022: $29.8MQ1 2023: $84.2MQ2 2023: $84.2MQ3 2023: $58.5MQ4 2023: $131.8MQ1 2024: $105.1MQ2 2024: $135.9MQ3 2024: $21.6MQ4 2024: $21.0MQ1 2025: $13.0MQ2 2025: $13.4MQ3 2025: $10.6MQ4 2025: $43.2MQ1 2026: $25.3MQ2 2026: $28.5M
Institutions holding VRCA and their total value by quarter
QuarterHoldersValue
Q2 202643$28.5M
Q1 202639$25.3M
Q4 202550$43.2M
Q3 202534$10.6M
Q2 202559$13.4M
Q1 202575$13.0M
Q4 202481$21.0M
Q3 202479$21.6M
Q2 202474$135.9M
Q1 202462$105.1M
Q4 202364$131.8M
Q3 202367$58.5M
Q2 202363$84.2M
Q1 202360$84.2M
Q4 202250$29.8M
Q3 202249$29.9M
Q2 202257$21.8M
Q1 202251$72.1M
Q4 202145$82.0M
Q3 202149$114.6M
Q2 202153$112.3M
Q1 202151$150.4M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q3 2022.

Institutions holding VRCA in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC5,038,983$13.9M0.40%00.0%Unchanged
FMR LLC1,597,876$4.39M0.00%−1790.0%Reduced
BML Capital Management, LLC1,110,605$3.05M2.92%+1,110,605New
Vanguard Group Inc1,022,788$2.81M0.00%+10,192+1.0%Added
Millennium Management LLC205,446$565.0K0.00%+131,372+177.4%Added
Geode Capital Management, LLC162,963$448.0K0.00%+12,728+8.5%Added
Renaissance Technologies LLC156,374$430.0K0.00%−73,926−32.1%Reduced
Steel Peak Wealth Management LLC136,361$375.0K0.03%+1,700+1.3%Added
Kornitzer Capital Management Inc129,251$355.4K0.01%00.0%Unchanged
Fosun International Ltd129,013$354.8K0.03%−153,395−54.3%Reduced
Conning Inc.129,013$354.8K0.01%+129,013New
Miracle Mile Advisors, LLC125,000$343.8K0.01%00.0%Unchanged
MML Investors Services, LLC99,350$273.0K0.00%+9,400+10.5%Added
BlackRock Inc.84,859$233.4K0.00%−194,437−69.6%Reduced
Bridgeway Capital Management, LLC74,550$205.0K0.01%+50,000+203.7%Added
Citadel Advisors LLC72,449$199.2K0.00%−1,005−1.4%Reduced
State Street Corp62,816$172.7K0.00%00.0%Unchanged
Two Sigma Investments, LP50,820$139.8K0.00%+1,927+3.9%Added
Northern Trust Corp47,813$131.5K0.00%−333−0.7%Reduced
Susquehanna International Group, LLP45,285$124.5K0.00%+10,284+29.4%Added
Ergoteles LLC35,552$97.8K0.00%+35,552New
Two Sigma Advisers, LP32,900$90.5K0.00%+20,300+161.1%Added
Kovitz Investment Group Partners, LLC30,125$83.0K0.00%+30,125New
Beck Mack & Oliver LLC30,000$82.5K0.00%00.0%Unchanged
Susquehanna Fundamental Investments, LLC28,000$77.0K0.00%00.0%Unchanged
LPL Financial LLC26,000$71.5K0.00%+4,000+18.2%Added
Bank of America Corp20,344$55.9K0.00%+630+3.2%Added
Creative Planning20,018$55.0K0.00%+5,237+35.4%Added
Jane Street Group, LLC18,052$49.6K0.00%+18,052New
Stifel Financial Corp16,125$44.3K0.00%+16,125New
Morgan Stanley13,257$36.5K0.00%−29,106−68.7%Reduced
Charles Schwab Investment Management Inc12,572$34.6K0.00%00.0%Unchanged
Bank of New York Mellon Corp11,497$31.6K0.00%−66−0.6%Reduced
Truist Financial Corp11,298$31.1K0.00%00.0%Unchanged
Simplex Trading, LLC9,385$25.0K0.00%+9,246+6,651.8%Added
Tower Research Capital LLC (TRC)6,358$18.0K0.00%−687−9.8%Reduced
Spire Wealth Management3,827$11.0K0.00%+3,827New
Group One Trading, L.P.3,720$10.2K0.00%−880−19.1%Reduced
Royal Bank of Canada2,847$8.00K0.00%+6+0.2%Added
UBS Group AG1,912$5.26K0.00%−3,598−65.3%Reduced
Wells Fargo & Company1,626$4.47K0.00%+3+0.2%Added
BNP Paribas Arbitrage, SA1,384$3.81K0.00%+874+171.4%Added
JPMorgan Chase & Co1,235$3.00K0.00%−1,466−54.3%Reduced
Asset Dedication, LLC1,193$3.00K0.00%00.0%Unchanged
Benjamin F. Edwards & Company, Inc.500$1.00K0.00%00.0%Unchanged
Federated Hermes, Inc.237$6520.00%+237New
Coppell Advisory Solutions LLC200$5500.00%+200New
CoreCap Advisors, LLC200$5500.00%+200New
Coppell Advisory Solutions Corp.200$5500.00%+200New
Carmichael Hill & Associates, Inc.21$580.00%00.0%Unchanged
Point72 Asset Management, L.P.0$00.00%−485,802−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−17,755−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−17,594−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−13,400−100.0%Sold out
HRT Financial LP0$00.00%−11,411−100.0%Sold out
Virtu Financial LLC0$00.00%−10,834−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−11,024−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−9,422−100.0%Sold out
Citigroup Inc0$00.00%−301−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−385−100.0%Sold out